FeesSafety
Pluang+

Bitcoin trades at a discount in the US despite rising institutional volume, signaling cautious market sentiment.

Market News
03 Nov 2026, 15:01 WIB
Tokenpost
View Source
Neutral
Bitcoin trades at a discount in the US despite rising institutional volume, signaling cautious market sentiment.

Bitcoin continues to trade at a discount in the US compared to overseas markets, with the Coinbase premium showing negative readings and a recent widening of this gap. Institutional trading volume on Coinbase Prime surged, indicating increased participation, but this does not confirm a buying bias as volume includes both buys and sells. Additional indicators such as CME leveraged fund positions and rising equity volatility suggest cautious sentiment among US investors. Market watchers will look for a narrowing US discount, sustained high institutional volume, and easing volatility to confirm stronger buying interest.

Bitcoin's US discount and institutional trading activity provide context for cryptocurrency market trends. For readers following crypto markets, here is Pluang's snapshot as of Nov 03, 2026 20:23 WIB: out of 50 major cryptocurrencies, 19 rose and 30 fell today. Among notable movers, COTI declined 3.52% with a typical hold time of 122 days and 57% sell orders, while AXS fell 2.75% but saw 62% buy orders and a shorter hold time of 63 days. CAKE dropped 2.71% with a strong 92% sell order activity and a 75-day hold time, illustrating varied investor behavior across assets.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
1 hour ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
1 hour ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
1 hour ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
2 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App